The FDA announced a temporary policy for certain Risk Evaluation and Mitigation Strategy (REMS) requirements for the duration of the COVID-19 public health emergency that has important implications for patients taking opioids.
MAY 6, 2020
MAY 6, 2020
The FDA announced a temporary policy for certain Risk Evaluation and Mitigation Strategy (REMS) requirements for the duration of the COVID-19 public health emergency that has important implications for patients taking opioids.